Auerbach Alan H's Form 4 filing
Puma Biotechnology, Inc. (PBYI) · filed Jan 8, 2026
- Accession no.
- 0001437749-26-000924
- Filed
- Jan 8, 2026
- Trade date
- Jan 6-7, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $204.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Auerbach Alan HCIK 0001358285 | Director, Officer (President and CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Common Stock | SSaleDisposed | −16,938 | $5.84 | −$98,917.92 | 7,163,963 | Direct | |
| Jan 7, 2026 | Common Stock | SSaleDisposed | −18,012 | $5.88 | −$105,910.56 | 7,145,951 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.